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Purpose: To report a patient with cavernous hemangioma (CH) presenting as a
“subcutaneous” lower eyelid mass.
Case report: A 37-year-old man presented with a painless and palpable mass over the
right lower eyelid for two years prior to referral. Computed tomography scan revealed a
well-defined, lobulated mass located in the mid and lateral portion of the lower eyelid
that extended posteriorly to the anterior orbital space. A transcutaneous excisional
biopsy was performed. Histopathologic findings of the tumor confirmed CH. Most CHs
are intraconal lesions, making our case an unusual presentation for this condition.
Conclusion:CHmay present superficially in the eyelid and anterior orbital area and thus,
although this location is not common, it should be kept in mind as a differential diagnosis
for any well-defined eyelid tumor.
Keywords: Cavernous Hemangioma; Eyelid Mass; Lower Eyelid Mass
J Ophthalmic Vis Res 2020; 15 (2): 236–239
INTRODUCTION
Cavernous hemangioma (CH) is the most common
benign orbital tumor in adults. It is most commonly
seen in middle-aged women and usually
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presents as a gradually increasing, painless, axial
proptosis with a single well-defined and slow-
growing intraconal mass.[1–3]
CH can also infrequently develop in the
extraconal orbital space producing non-
axial proptosis. The involvement of adnexal
tissues including conjunctiva, lacrimal gland,
and even orbital bones has rarely been
reported. To the best of our knowledge,
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Figure 1. Clinical photography of the patient showing a nodular subcutaneous mass about 1 cm below the right lower lid margin
which is more prominent in the upward gaze and skin depigmentation overlying the lesion. (Arrow shows the lesion) (A) Primary
position. (B) Upward gaze.
Figure 2. Orbital CT scan shows a well-defined mass in the inferotemporal extraconal space of the right orbit which has a single
lobe posteriorly and changes to bilobed anteriorly. (A) Coronal view of the anterior orbital space. (B) Axial view of the inferior
orbital space.
there are very few reports of eyelid CH in the
literature.[4–8] Herein, we report a patient with
eyelid CH presenting as a subcutaneous lower
eyelid mass.
CASE REPORT
A 37-year-old man presented with a painless mass
on the right lower eyelid, which gradually grew
over two years prior to referral. He reported no
fluctuation in the size of the mass with Valsalva
maneuver or exercises.
On examination, a nodular subcutaneous lesion
was noted slightly lateral to the midline of the right
lower lid, and about 1 cm inferior to the lid margin.
The lesion became more prominent in upward
gaze and a small area of skin depigmentation was
observed overlying the lesion [Figures 1(a) and 1(b)].
Palpation of the mass revealed a firm, freely
mobile subcutaneous mass. No proptosis was
noted. Visual acuity, extraocular muscle move-
ments, and pupillary reflexes were normal. Anterior
and posterior segment examinations were also
within normal limits.
CT scan of the orbit showed a lobulated soft
tissue mass with a well-defined border in the
temporal area of the right lower lid, which extended
to the extraconal inferior orbital space. The mass
had one lobe posteriorly andwas bilobed anteriorly
[Figures 2(a) and 2(b)]. The patient refused imaging
with contrast.
The lesion was removed using a transcutaneous
approach over the mass by blunt dissection while
being pushed anteriorly by a malleable retractor in
the lower lid fornix. A dark violet well-encapsulated
mass measuring 1.3 × 1.2 × 1 cm was excised.
The mass had two anterior fused lobes which
unified into a single lobe posteriorly [Figure 3(a)].
Histopathologic examination showed dilated thick
wall spaces with a single layer of endothelium
loaded with blood cells and areas of thrombosis.
There was also a hypercellular stroma and a well-
defined capsule. These histological findings were
consistent with CH [Figure 3(b)].
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Figure 3. (A) Intraoperative view of the mass shows a dark-red encapsulated mass which is seen bilobed in the anterior view. (B)
Microscopic pathology shows dilated thick wall spaces with a single layer of endothelium loaded with blood cells and thrombosis
and a well-defined capsule typical of orbital cavernous hemangioma (Hematoxylin and Eosin, magnification × 100).
The operation and postoperative course were
uneventful. Follow-up was done in 12 months.
DISCUSSION
The origin of CH is controversial. Some authors
classify CH as low flow venous malformations,
while others believe that CH lesions are indeed low
flow arteriovenous malformations.[1–3, 9] Orbital CH
is essentially a gradual growing lesion; however, it
has been shown that CH has a more rapid growth
in extraconal locations and in male subjects.[10]
As was seen in our case, CH has a predilection
for lateral and inferior orbital spaces, which is
attributed to the rich arterial flow in the area.[11]
CH is one of the common vascular lesions in the
liver and subcutaneous tissues, but in those areas,
they typically have no prominent capsule. This is
in contrast to the orbital space, in which a well-
defined capsule is a characteristic feature.[9, 12] In
our case, although presenting with a subcutaneous
mass, the presence of a well-defined capsule was
in favor of the orbit as the origin of the CH. This
means that a CH may have some characteristics of
subcutaneous CH and other characteristics of its
orbital counterpart.
Eyelid presentations have rarely been reported
in large studies of orbital CH. A palpable mass was
reported in 19.6% of patients in a study on 214 cases
of orbital CH.[13] However, orbital CH extending to
the subcutaneous areas was seen in 9.3% and 5.1%
of the patients in the studies by Aymard et al[14] and
Rootman et al,[1] respectively.
In most previously reported cases, eyelid CH
lesions were located in the upper lid subcutaneous
area [4–7], whereas, there was only one case report
of lower eyelid CH[8] in which the patient com-
plained of proptosis and not an eyelid mass.
Finally, although CH of the eyelid is unusual, it
should be considered in the list of differential diag-
nosis of subcutaneous eyelid lesions and surgeons
should be prepared for a vascular lesion.
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